Leflunomide in the treatment of palmoplantar pustulosis.
Melwani
Priti Mohan
PM
Department of Dermatology, Hospital Universitario Insular de Gran Canaria, Avda. Marítima del Sur s/n 35016, Las Palmas de Gran Canaria, Spain. pritimelwani@hotmail.com
Peñate
Yeray
Y
Guillermo
Noemi
N
Soler
Elena
E
Hernández-Machín
Buenaventura
B
Borrego
Leopoldo
L
D000328:Adult; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006229:Hand Dermatoses / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007555:Isoxazoles / Q000009:adverse effects / Q000627:therapeutic use*; D000077339:Leflunomide; D011565:Psoriasis / Q000175:diagnosis / Q000188:drug therapy*; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide